Remission of Acute Myeloblastic Leukemia After Severe Pneumonia Treated With High-Dose Methylprednisolone

  • Yoko Shimohakamada
  • Kenji Shinohara
  • Naofumi Fukuda
Case Report


We report a case of acute myeloblastic leukemia (AML)-M2 (by French-American-British classification) with t(8;21) (q22;q22) that was complicated with severe pneumonia. The patient tested positive by fluorescence in situ hybridization (FISH) for AML1 splitting and positive by reverse transcriptase polymerase chain reaction (RT-PCR) for chimeric AML1/ MTG8 messenger RNA (mRNA), which indicated splitting of the MTG8 gene on chromosome 8 (q22) and the AML1 gene on chromosome 22 (q22). High-dose methylprednisolone was administered, and the leukemic cells disappeared without chemotherapy, although dysplastic hematopoietic cells were observed transiently after the first therapy. After the disappearance of leukemic cells, FISH for AML1 splitting was negative, and real-time PCR results for quantitative chimeric AML1/ MTG8 mRNA were less than the detectable level, however, RT-PCR results for AML1/MTG8 mRNA remained positive. These findings suggest that the patient acquired morphological, cytogenetic, and possibly molecular genetic remission by the synergistic effects of severe infection and high-dose methylprednisolone.

Key words

AML Spontaneous remission Infection Corticosteroid 


  1. 1.
    Martelli MP, Latagliata R, Spadea A, et al. Molecular and cytoge-netic remission in a case of subtype M4E acute myelogenous leukemia with minimal monochemotherapy: high sensitivity or spontaneous remission?Eur J Haematol. 2000;65:203–206.PubMedCrossRefGoogle Scholar
  2. 2.
    Lachant NA, Goldberg J, Nelson DA, et al. Spontaneous remission in acute myelogenous leukemia in the adult.Am J Med. 1979;67:687–692.PubMedCrossRefGoogle Scholar
  3. 3.
    Ifrah N, James J-M, Viguie F, et al. Spontaneous remission in adult acute leukemia.Cancer. 1985;56:1187–1190.PubMedCrossRefGoogle Scholar
  4. 4.
    Jimemez C, Ribera JM, Abad E, et al. Increased serum tumor necrosis factor during transient remission in acute leukemia.Lancet. 1993;34:1600.CrossRefGoogle Scholar
  5. 5.
    Paul R, Remes K, Lakkala T, et al. Spontaneous remission in acute myeloid leukaemia.Br J Haematol. 1994;86:210–212.PubMedCrossRefGoogle Scholar
  6. 6.
    Musto P, D’Arena G, Mellillo L, et al. Spontaneous remission in acute myeloid leukaemias: a role for endogenous production of tumor necrosis factor and interleukin-2?Br J Haematol. 1994;87:879–880.PubMedCrossRefGoogle Scholar
  7. 7.
    Delmer A, Heron E, Marie J-P, et al. Spontaneous remission in acute myeloid leukaemia.Br J Haematol. 1994;87:880–882.PubMedCrossRefGoogle Scholar
  8. 8.
    Mitterbauer M, Fritzer-Szekeres M, Mitterbauer G, et al. Spontaneous remission of acute myeloid leukemia after injection and blood transfusion associated with hypergammaglobulinemia.Ann Hematol. 1996;73:189–193.PubMedCrossRefGoogle Scholar
  9. 9.
    Crabtree GR, Smith KA, Munck A. Glucocorticoid receptors and sensitivity of isolated human leukemia and lymphoma cells.Cancer Res. 1978;38:4268–4272.PubMedGoogle Scholar
  10. 10.
    Kaspers GJL, Pieters R, Klumper E, et al. Glucocorticoid resistance in childhood leukemia.Leuk Lymph. 1994;13:187–201.CrossRefGoogle Scholar
  11. 11.
    Hisconmez G, Ozsoylu S, Tuncer M. Differentiation of myeloid leukemic cells induced by high-dose methylprednisolone in patients with acute myeloblastic leukemia and its therapeutic potential.Leuk Res. 1991;15:537–541.CrossRefGoogle Scholar
  12. 12.
    Hisconmez G, Erdemli E,Tekelioglu M, et al. Morphologic evidence of apoptosis in childhood acute myeloblastic leukemia treated with high-dose methylprednisolone.Leuk Lymph. 1996;22:91–96.CrossRefGoogle Scholar
  13. 13.
    Miyoshi H, Ohki M, Nakagawa T, et al. Glucocorticoids induce apoptosis in acute myeloid leukemia cell lines with a t(8;21) chromosome translocation.Leuk Res. 1997;21:45–50.PubMedCrossRefGoogle Scholar
  14. 14.
    Ozbek N, Erdemli E, Hisconmez G, et al. Effects of methylpred-nisolone of human myeloid leukemic cells in vitro.Am J Hematol. 1999;60:255–259.PubMedCrossRefGoogle Scholar
  15. 15.
    Oster W, Mertelsmann R, Herrmann F. Role of colony-stimulating factors in the biology of acute myelogenous leukemia.Int J Cell Cloning. 1989;7:13–29.PubMedCrossRefGoogle Scholar
  16. 16.
    Miyamoto T, Nakafuji K, Harada M, et al. Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cells harvests from patients with t(8;21) acute myelogenous leukemia.Br J Haematol. 1995;91:132–138.PubMedCrossRefGoogle Scholar
  17. 17.
    Miyamoto T, Nakafuji K, Akashi K, et al. Persistence of multipo-tent progenitors expressing AML/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.Blood. 1996;87:4789–4796.PubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2001

Authors and Affiliations

  • Yoko Shimohakamada
    • 1
  • Kenji Shinohara
    • 1
  • Naofumi Fukuda
    • 1
  1. 1.Division of Hematology, Department of MedicineYamaguchi Prefecture Central HospitalHofuJapan
  2. 2.Division of Hematology, Department of MedicineYamaguchi Prefecture Central HospitalHofuJapan

Personalised recommendations